BioCentury
ARTICLE | Clinical News

Biocompatibles stent data

February 1, 2000 8:00 AM UTC

Biocompatibles (LSE:BII) said that the DISTINCT study of its BiodivYsio phosphorylcholine-coated stent met its end points of showing equivalence to a marketed stent. The company has submitted two of t...